Northeast Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 6/6
Northeast Pharmaceutical Group has a total shareholder equity of CN¥5.4B and total debt of CN¥2.1B, which brings its debt-to-equity ratio to 39.7%. Its total assets and total liabilities are CN¥14.5B and CN¥9.1B respectively. Northeast Pharmaceutical Group's EBIT is CN¥314.8M making its interest coverage ratio -5.1. It has cash and short-term investments of CN¥5.1B.
Key information
39.7%
Debt to equity ratio
CN¥2.12b
Debt
| Interest coverage ratio | -5.1x |
| Cash | CN¥5.08b |
| Equity | CN¥5.35b |
| Total liabilities | CN¥9.14b |
| Total assets | CN¥14.50b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 000597's short term assets (CN¥9.4B) exceed its short term liabilities (CN¥8.8B).
Long Term Liabilities: 000597's short term assets (CN¥9.4B) exceed its long term liabilities (CN¥350.8M).
Debt to Equity History and Analysis
Debt Level: 000597 has more cash than its total debt.
Reducing Debt: 000597's debt to equity ratio has reduced from 114.7% to 39.7% over the past 5 years.
Debt Coverage: 000597's debt is well covered by operating cash flow (32.5%).
Interest Coverage: 000597 earns more interest than it pays, so coverage of interest payments is not a concern.